Franklin Resources, Inc. 13D and 13G filings for Acumen Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-06 09:02 am Purchase |
2023-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS |
FRANKLIN RESOURCES INC BEN |
3,358,809 5.800% |
3,358,809 (New Position) |
Filing |